Topcon Corporation announces that following the successful completion of a management buyout (“MBO”), under which Topcon’s management team has acquired the Company, Topcon’s shares were delisted from the stock exchange as of December 2, 2025.

 Through this MBO, Topcon has formed a strong partnership with KKR Japan Co., Ltd. and JIC Capital, Ltd., who have a deep understanding of our businesses and a strong alignment with our corporate philosophy, to establish a more agile and flexible management structure. This will enable us to accelerate strategic initiatives from a long-term perspective, including bold upfront investments, further strengthen Topcon’s competitiveness and drive the sustainable growth of our corporate value. Following the transition to a private company, the current management team will continue to lead and operate Topcon as before.

Topcon Healthcare, Inc. (La Jolla, CA) will remain focused on executing our long-term strategy of Healthcare from the Eye™ with clarity and discipline advancing solutions that use the eye as a window to systemic health and enabling more connected, data-driven care at scale.

Thank you for your continued partnership and support for Topcon’s future growth.


MCA#6190